ATI RN
ATI Comprehensive Exit Exam 2023 With NGN
1. A nurse is preparing to administer potassium chloride IV to a client who has hypokalemia. Which of the following actions should the nurse take?
- A. Give the medication as a bolus over 10 minutes.
- B. Dilute the medication before administration.
- C. Infuse the medication at a rate of 10 mEq/hr.
- D. Administer the medication undiluted.
Correct answer: C
Rationale: The correct action the nurse should take when administering potassium chloride IV to a client with hypokalemia is to infuse the medication at a rate of 10 mEq/hr. This slow infusion rate is crucial to prevent the development of hyperkalemia, a potentially dangerous condition. Option A is incorrect because giving the medication as a bolus over 10 minutes can lead to adverse effects. Option B is incorrect as potassium chloride does not necessarily need to be diluted before administration in this scenario. Option D is incorrect as administering the medication undiluted can also increase the risk of hyperkalemia.
2. A nurse is caring for a client who has acute pancreatitis. Which of the following interventions should the nurse take?
- A. Encourage oral intake of clear liquids
- B. Administer an antiemetic before meals
- C. Insert a nasogastric tube for suction
- D. Place the client in a supine position
Correct answer: C
Rationale: In acute pancreatitis, the gastrointestinal tract needs to rest to reduce pancreatic enzyme secretion. Inserting a nasogastric tube for suction helps decompress the stomach and reduce stimulation of the pancreas. Encouraging oral intake of clear liquids (Choice A) or administering an antiemetic before meals (Choice B) may aggravate the condition by stimulating the pancreas. Placing the client in a supine position (Choice D) may not directly address the underlying issue of reducing pancreatic stimulation.
3. A healthcare provider is reviewing the medical record of a client who has schizophrenia and is taking clozapine. Which finding should the healthcare provider identify as a contraindication to the administration of clozapine?
- A. Heart rate 58/min.
- B. Fasting blood glucose 100 mg/dL.
- C. Hgb 14 g/dL.
- D. WBC count 2,900/mm3.
Correct answer: D
Rationale: The correct answer is D: a low WBC count. Clozapine can suppress bone marrow function, leading to a decreased white blood cell count. This condition, known as agranulocytosis, increases the risk of severe infections. Monitoring WBC counts is essential during clozapine therapy. Choices A, B, and C are within normal ranges and are not contraindications for administering clozapine.
4. A healthcare provider is performing a skin assessment for a client and observes several skin lesions. Which of the following findings is a priority to report to the provider?
- A. Raised nevus
- B. Macule
- C. Vesicle
- D. Irregularly shaped mole
Correct answer: D
Rationale: An irregularly shaped mole is a priority finding to report to the provider as it can be indicative of melanoma, a type of skin cancer. Melanoma is a serious condition that requires prompt evaluation and treatment. Raised nevus, macule, and vesicle are common skin findings that are typically benign and may not require immediate attention. Therefore, the irregularly shaped mole stands out as the priority due to its association with potential malignancy.
5. A nurse is caring for a client who is receiving oxytocin IV for augmentation of labor. The client's contractions are occurring every 45 seconds with a nine-second duration, and the fetal heart rate is 170 to 180 beats per minute. Which of the following actions should the nurse take?
- A. Discontinue oxytocin infusion
- B. Increase oxytocin infusion
- C. Decrease oxytocin infusion
- D. Maintain oxytocin infusion
Correct answer: A
Rationale: In this scenario, the client is experiencing frequent contractions with a short duration and an elevated fetal heart rate, indicating potential fetal distress. Discontinuing the oxytocin infusion is crucial to prevent further complications and restore normal fetal parameters. Increasing or maintaining the oxytocin infusion could exacerbate the situation, leading to more distress for the fetus. Decreasing the oxytocin infusion may not be sufficient to address the current issue and could delay the improvement of fetal well-being.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access